Hetronifly in combination with chemotherapy was shown to improve survival of patients with extensive stage small cell lung ...
The growth of AI in the healthcare sector is already having real-world impacts and promises a step-change in future care.
In a study published in Advanced Functional Materials, a research team from the Shanghai Institute of Materia Medica (SIMM) ...
PsyPost on MSN1h
Research shows diabetes drug could reduce dementia risk. Here’s how the two diseases may be linkedA Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be ...
The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...
Beyond MariTide, Amgen has a rich pipeline with more than 30 phase 3 programs. Some are for existing medicines seeking label expansions, such as Lumakras and Amjevita, a rheumatoid arthritis medicine.
Merck and Daiichi Sankyo's HER3 antibody-drug conjugate reported a positive phase 3 result in EGFR-mutated lung cancer. Merck ...
Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...
The Food and Drug Administration issued a rule in March 2023 that requires health care professionals to notify people if they have dense breasts. Studies have shown dense breast tissue can make it ...
Researchers have now found a substance that effectively combats glioblastomas, at least in the laboratory: an antidepressant ...
Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...
Controversial fentanyl lollipops and similar products will no longer be made by drug makers, the U.S. Food and Drug A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback